We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Centocor Ortho Biotech Acquires Respivert to Strengthen Pulmonary Focus

News   Jun 14, 2010

 
Centocor Ortho Biotech Acquires Respivert to Strengthen Pulmonary Focus
 
 
Advertisement
 

RELATED ARTICLES

Blood-Based Test Accurately Identifies Viral Infection Before Symptoms Develop

News

A team of Duke Health scientists have identified biomarkers that accurately identify numerous viral infections across the clinical stages of disease, advancing a potential new way to guide treatment, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases.

READ MORE

Why Do Some People With COVID-19 Develop Severe Disease?

News

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19.

READ MORE

Ultrapotent Compound Could Help Combat C. difficile

News

Scientists from Purdue University have advanced novel compounds that they have designed to help treat patients with Clostridioides difficile.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE